[Mogamulizumab for the treatment of ATL and PTCL]

Gan To Kagaku Ryoho. 2015 May;42(5):553-7.
[Article in Japanese]
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Humans
  • Immunotherapy
  • Leukemia-Lymphoma, Adult T-Cell / drug therapy*
  • Lymphoma, T-Cell, Peripheral / drug therapy*
  • Molecular Targeted Therapy
  • Receptors, CCR4 / immunology

Substances

  • Antibodies, Monoclonal, Humanized
  • Receptors, CCR4
  • mogamulizumab